Poland· PL-100370308
Naloxonum hydrochloricum WZF
A naloxone product containing naloxoni hydrochloridum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Naloxone is registered in 11 of 19 countries.
Countries holding a registration under ATC V03AB15 (naloxone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Naloxone · ATC V03AB15
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Naloxoni hydrochloridum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- V03AB15
- ATC class
- Naloxone
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991275044
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
104 interactions on record for naloxone.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naloxone · interactions on record
104 records
- 2 severe
- 34 moderate
- 4 minor
- 64 info
Most severe, free to view
- DroperidolN01AX01severe
- DroperidolN05AD08severe
- Methylnaltrexone bromideA06AH01moderate
- NaloxegolA06AH03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Naloxone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNALOXONE POLPHARMAZaklady Farmaceutyczne Polpharma SA, Starogard Gdański
- FinlandNarcantiBristol-Myers Squibb Ab
- United StatesKLOXXADOHikma Specialty USA Inc.
- United KingdomNaloxone 1.26mg/0.1ml nasal spray unit doseAccord-UK Ltd
- GermanyNaloxon AccordAccord Healthcare B.V.
- BelgiumNaloxon B. Braun 0.4 mg/mlB. Braun Melsungen
- CanadaINJECTABLE NALOXONE HYDROCHLORIDEOMEGA LABORATORIES LIMITED
- SwedenNaloxon actrevo 3,6 mg Nässpray, lösning i endosbehållareActrevo GmbH
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Forvel, Naloxon Accord
- Belgium · Naloxon B. Braun
- Bulgaria · Форвел
- Cyprus · Codaxol, Forvel
- Czechia · Forvel, Naloxone Polpharma
- Germany · Naloxon Accord, Naloxon B. Braun
- Denmark · Forvel, Naloxon B. Braun
- Estonia · Forvel, Ventizolve
- Spain · Fomed, Naloxona B. Braun
- Finland · Naloxone Accord, Nexodal
- France · Naloxone Accord, Naloxone Adapt Pharma
- United Kingdom (Northern Ireland) · Naloxone Accord-Uk, Naloxone B. Braun Melsungen
- Greece · Forvel, Νaloxon B.Braun
- Croatia · Forvel
- Hungary · Nexodal
- Ireland · Naloxone Hydrochloride Accord, Naloxone Hydrochloride Mercury Pharmaceuticals (Ireland)
- Iceland · Naloxon B. Braun, Nyxoid
- Italy · Naloxone Accord, Naloxone Adapt
- Liechtenstein · Nyxoid
- Lithuania · Forvel
- Luxembourg · Naloxon B. Braun
- Latvia · Forvel
- Malta · Forvel
- Netherlands · Naloxon Hci B. Braun, Naloxon Hcl Accord
- Norway · Naloxon B. Braun, Naloxon Hameln
- Portugal · Forvel, Naloxona Accord
- Romania · Forvel
- Sweden · Naloxon Actrevo, Naloxon Hameln
- Slovenia · Nexodal
- Slovakia · Naloxone Polpharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/35d17ced-98a2-4921-afa3-64751c58d88a GET /v1/drugs/35d17ced-98a2-4921-afa3-64751c58d88a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "400 mcg/ml",
"packaging": "05909991275044 ¦ Lz ¦ 115655\n10 amp. 1 ml",
"substance": "Naloxoni hydrochloridum 400 mcg/ml",
"common_name": "Naloxoni hydrochloridum",
"pl_product_id": "100370308",
"pozwolenie_nr": "247/16",
"auth_procedure": "IR",
"authorisation_validity": "2031-04-29"
}See everything about naloxone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.